IMCD Buys Canada’s L.V. Lomas

(c) IMCD
(c) IMCD

In its second North American acquisition this year, IMCD is to acquire Canadian and US specialty chemicals and ingredients distributor, L.V. Lomas. Financial terms were not disclosed but IMCD said it would fund the acquisition from available cash and existing bank facilities.

Lomas represents IMCD’s first step into Canada and also boosts the Dutch group’s position in the US, following its recent purchase of Houston, Texas-headquartered Bossco Industries.

Commenting on the deal, IMCD’s CEO, Piet van der Slikke, said: “This is an important step in the further development of IMCD's North America region as it not only expands our geographical presence into Canada in all core markets but also further strengthens our US organization and coverage.”

Rand Lomas, chairman of L.V. Lomas added: “Together we will become a market leader in North America for the sales, marketing and distribution of specialty chemicals and food and pharmaceutical ingredients.”

Headquartered in Toronto, L.V. Lomas has offices in Montreal and Vancouver as well as operations at six locations in Canada and the US. The business generated revenues of C$383 million in 2016 and employs approximately 280 people.

The transaction, which is subject to the usual closing and regulatory conditions, is expected to close at the end of August.

In separate news, IMCD has signed an exclusive agreement with Givaudan to distribute the Swiss company’s flavors range in food and nutrition markets in Germany, France, Italy, Spain, Benelux, the UK and Nordic countries.

“This relationship will allow us to reach a whole new customer base of small- to medium-sized enterprises where we can add value and help customers create inspiring products which delight consumers,” said Kevin Robinson, Givaudan’s commercial head of Western Europe.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
19.05.2025 • NewsChemie

OQ Chemicals firmiert künftig wieder als Oxea

Der bis Mai 2020 unter dem Namen Oxea bekannte Hersteller von Oxo-Zwischenprodukten und Oxo-Derivaten, der zwischenzeitlich zum Omanischen Energieunternehmen OQ gehörte und unter dem Namen OQ Chemicals firmierte, kehrt zu seinem alten Namen und seinen Wurzeln zurück.